Redefining Payer Research for Smarter Market Access
In the healthcare landscape, understanding payer perspectives is critical to achieving successful market access. PayerPro360 is an AI-powered platform designed to transform how pharma and biotech companies conduct payer research.
By combining advanced technology with deep domain expertise, PayerPro360 enables you to access real-time insights, engage with the right payer stakeholders, and make faster, data-driven decisions without the limitations of traditional research methods.
3000+
Global Payer Experts
8+
Payer Categories (Public, Private, etc.)
31+
Global Markets Covered
20+
Therapy Areas Expertise
Real-time Response Collection
Instant Payer Insights
Multiple Output Formats
(Dashboards, Reports, Raw Data)
How PayerPro360 Supports Your Success
Bridge the gap between fragmented data and actionable insights with our comprehensive epidemiology and market access intelligence
Challenge
- Difficulty identifying and recruiting the right payer profiles
- Time-consuming and costly telephonic research methods
- Limited flexibility in designing payer-specific research
- Lack of real-time insights in dynamic market environments
- Complexities in understanding global and emerging market access dynamics
Solution
- AI-driven platform with a global payer network
- Custom questionnaire builder for targeted insights
- Real-time data collection and visibility into responses
- Flexible, scalable, and GDPR-compliant infrastructure
Outcomes
- Faster, more accurate payer insights
- Improved market access strategies
- Reduced research timelines and costs
- Better-informed decision-making with real-world data
Why Teams Choose PayerPro360
A comprehensive suite of intelligence tools designed to navigate the entire product lifecycle—from initial epidemiology to strategic market planning.
Client Reviews
Trusted by global pharmaceutical leaders to deliver precision in patient share estimations and therapeutic benchmarking.
“Support on current drug utilizations and benchmarking of emerging therapy, greatly helped us in narrowing down on patient share estimations for internal calculations ״
Santen PharmaDirector
“Patient share for approved therapies are estimated perfectly. Indeed it's great pieces of work. I liked the way segmentation was shown and patient flow was discussed״
Vicore PharmaDirector
“Happy to read the market insight report, really informative and applied to build marketing strategy״
NewronDirector
“This is the first time I worked with Thelansis, I could say the team is truly professional, Cheers guys ״
SanquinDirector
“ We want to congratulate team Thelansis for their continuous support during this tough time ״
WEX TherapeuticsDirector
"We are really fortunate to interact with Thelansis' Forecasting team, well seasoned professionals who understand what's the actual need "
Reata PharmaceuticalsVice President
" We are really fortunate to interact with Thelansis' Forecasting team, well seasoned professionals who understand what's the actual need "
Stemline TherapeuticsVice President- Marketing
"Some great piece of patient based forecast model; and market assumptions. Tying up beautifully with the payer's insights "
CamurusDirector
"Liked the way the outcome was structured. Regulatory assessment was spot-on. Country-wise regulatory scenarios were gold to us at this point"
Asarina PharmaDirector
"Satisfied with the companies core competency around Clinical Trial Outcome analysi"
Acadia PharmaceuticalsDirector
Unlock faster, smarter payer insights with PayerPro360
Let’s discuss how it can accelerate your market access strategy.